Analyze Diet

Diagnostic testing for pituitary pars intermedia dysfunction in horses.

Abstract: Pituitary pars intermedia dysfunction is a slowly progressive disorder that afflicts most breeds of horses. Because it shares features with human Cushing disease, it has been referred to as equine Cushing disease. A variety of tests of pituitary-adrenocortical function were performed on horses with evidence of pituitary pars intermediate dysfunction, and results were compared with those in healthy control horses. Diurnal variations in plasma cortisol concentration were not statistically different between control horses and those with pituitary pars intermedia dysfunction. An ACTH stimulation (1 U of natural ACTH gel/kg of body weight, IM) test or a combined dexamethasone suppression test (10 mg, IM) and ACTH stimulation (100 mg of synthetic ACTH, IV) test also failed to distinguish horses with pituitary pars intermedia dysfunction from control horses. A significant (P < 0.001) dose-related suppression of cortisol concentration in response to increasing doses (5, 10, 20, and 40 micrograms/kg) of dexamethasone was observed in control horses but not in those with pituitary pars intermedia dysfunction. On the basis of plasma cortisol concentration, the dexamethasone suppression test, using 40 micrograms/kg, whether initiated at 5 PM with sample collection at 15 (8 AM) and 19 (12 PM) hours after dexamethasone administration, or initiated at 12 AM with sample collection at 8 (8 AM), 12 (12 PM), 16 (4 PM), 20 (8 PM), and 24 (12 AM) hours after dexamethasone administration, reliably distinguished between control horses and those with pituitary pars intermedia dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1994-02-15 PubMed ID: 8163420
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article examines different diagnostic tests for identifying pituitary pars intermedia dysfunction (PPID), a common disease in horses akin to human Cushing disease, assessing their efficacy and proposing a halt in cortisol response to heavy doses of dexamethasone as reliable method for diagnosis.

Introduction to Pituitary Pars Intermedia Dysfunction

  • Pituitary Pars Intermedia Dysfunction (PPID) is a slow-developing disorder that can affect horses of all breeds.
  • Due to its similarity to human Cushing’s disease, it is sometimes referred to as equine Cushing’s disease.
  • The disease affects the pituitary gland, an important part of the endocrine system, responsible for hormone regulation.

Testing for PPID

  • In this study, a range of tests were performed on horses suspected to have PPID. The test results of these horses were then compared with those of healthy, control horses.
  • These tests focused on the function of the pituitary-adrenocortical function, specifically on the secretion of cortisol, a key hormone that can indicate the presence of PPID.

Inconclusive Tests

  • The tests included the measurement of diurnal variations in plasma cortisol concentration, an ACTH stimulation test (using a natural ACTH gel), and a combined dexamethasone suppression test (using a synthetic ACTH).
  • All of these tests failed to show a significant difference between the control horses and the horses suspected of having PPID, proving them ineffectual for reliable detection of the disease.

Dexamethasone Suppression Test

  • The researchers found a significant suppression of cortisol concentration in response to increasing doses of dexamethasone in control horses. However, this suppression was not observed in horses suspected of having PPID.
  • The lack of cortisol suppression in response to dexamethasone thus emerged as a reliable diagnostic marker for PPID in horses.

Conclusion

  • The researchers concluded that the dexamethasone suppression test, specifically involving administration of heavy doses of dexamethasone, is a reliable method for differentiating between healthy horses and those with PPID.
  • They suggested that this test should be conducted by administering dexamethasone (40 micrograms/kg) either in the evening with sample collection the following morning and noon, or at midnight with sample collection at multiple intervals the next day.

Cite This Article

APA
Dybdal NO, Hargreaves KM, Madigan JE, Gribble DH, Kennedy PC, Stabenfeldt GH. (1994). Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc, 204(4), 627-632.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 204
Issue: 4
Pages: 627-632

Researcher Affiliations

Dybdal, N O
  • Department of Pathology, School of Veterinary Medicine, University of California, Davis 95616.
Hargreaves, K M
    Madigan, J E
      Gribble, D H
        Kennedy, P C
          Stabenfeldt, G H

            MeSH Terms

            • Adrenocorticotropic Hormone
            • Animals
            • Circadian Rhythm
            • Dexamethasone
            • Evaluation Studies as Topic
            • Female
            • Horse Diseases / diagnosis
            • Horses
            • Hydrocortisone / blood
            • Male
            • Pituitary Diseases / diagnosis
            • Pituitary Diseases / veterinary
            • Pituitary Function Tests / veterinary
            • Pituitary Gland / physiopathology

            Citations

            This article has been cited 10 times.
            1. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet Sci 2022 Oct 10;9(10).
              doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
            2. Nitzsche AM, Fey K, Büttner K, Gröf M, Staszyk C. The Gingiva of Horses With Pituitary Pars Intermedia Dysfunction: A Macroscopic Anatomical Evaluation.. Front Vet Sci 2021;8:786971.
              doi: 10.3389/fvets.2021.786971pubmed: 35146012google scholar: lookup
            3. Horn R, Stewart AJ, Jackson KV, Dryburgh EL, Medina-Torres CE, Bertin FR. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.. J Vet Intern Med 2021 Jan;35(1):560-570.
              doi: 10.1111/jvim.16017pubmed: 33368633google scholar: lookup
            4. Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC 2nd. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.. BMC Vet Res 2020 Sep 25;16(1):356.
              doi: 10.1186/s12917-020-02565-3pubmed: 32977825google scholar: lookup
            5. Hu K, Stewart AJ, Yuen KY, Hinrichsen S, Dryburgh EL, Bertin FR. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.. J Vet Intern Med 2020 May;34(3):1350-1356.
              doi: 10.1111/jvim.15771pubmed: 32255541google scholar: lookup
            6. Held F, Ekstrand C, Cvijovic M, Gabrielsson J, Jirstrand M. Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols.. J Pharmacokinet Pharmacodyn 2019 Feb;46(1):75-87.
              doi: 10.1007/s10928-018-09617-0pubmed: 30673914google scholar: lookup
            7. Morgan RA, Keen JA, Homer N, Nixon M, McKinnon-Garvin AM, Moses-Williams JA, Davis SR, Hadoke PWF, Walker BR. Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction.. Endocrinology 2018 Nov 1;159(11):3791-3800.
              doi: 10.1210/en.2018-00726pubmed: 30289445google scholar: lookup
            8. Spelta CW. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.. Vet Med (Auckl) 2015;6:293-300.
              doi: 10.2147/VMRR.S74191pubmed: 30101114google scholar: lookup
            9. Carmalt JL, Waldner CL, Allen AL. Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.. Can J Vet Res 2017 Oct;81(4):261-269.
              pubmed: 29081583
            10. Rendle DI, Duz M, Beech J, Parkin T, Durham AE. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.. J Vet Intern Med 2015 Jan;29(1):355-61.
              doi: 10.1111/jvim.12489pubmed: 25312676google scholar: lookup